Why We Need an Alzheimer's Moonshot in 2022

Thomas KR , Bangen KJ , Weigand AJ , et al. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology 2020; 94(4): e397–e406.

McGinley L . The controversial approval of an Alzheimer's drug reignites the battle over the underlying cause of the disease. Washington Post . Published: July 16, 2021. Accessed: March 29, 2022. https://www.washingtonpost.com/health/2021/07/05/aduhelm-new-alzheimers-drug-amyloid/.

Sachs R . The FDA's Approval Of Aduhelm: Potential Implications Across A Wide Range Of Health Policy Issues And Stakeholders. Health Affairs . Published: June 10, 2021. Accessed: March 29, 2022. https://www.healthaffairs.org/do/10.1377/forefront.20210609.921363/full/.

Kapadia R . The Other Pandemic: What to Do About the Coming Alzheimer's Crisis. Barron's . Published: February 5, 2021. Updated: February 7, 2021. Accessed: March 29, 2022. https://www.barrons.com/articles/the-coming-alzheimers-crisisand-what-to-do-about-it-51612543200?st=udn46dv4ahc76ar.

Suneson G , Byrnes H . Alzheimer's disease to affect 7.1 million Americans by 2025. Here's the expected increase by state. USA Today . Published: August 10, 2020. Accessed: March 29, 2022. https://www.usatoday.com/story/money/2020/08/10/alzheimers-disease-states-where-cases-will-rise-most-by-2025/42187567/.